Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 737917

Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT)

McKendrick, J. J; Cassidy, J.; Chakrapee- Sirisuk, S.; Fountzilas, G.; Iveson, T.; Jelic, S.; Karnicka-Mlodkowska, H.; Ostojic, Rajko; Scheithauer, W.; Twelves, C.
Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT) // Journal of Clinical Oncology
International conference, 2004. str. 3578-3578 (predavanje, međunarodna recenzija, sažetak, znanstveni)

CROSBI ID: 737917 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT)

Autori
McKendrick, J. J ; Cassidy, J. ; Chakrapee- Sirisuk, S. ; Fountzilas, G. ; Iveson, T. ; Jelic, S. ; Karnicka-Mlodkowska, H. ; Ostojic, Rajko ; Scheithauer, W. ; Twelves, C.

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Journal of Clinical Oncology / - , 2004, 3578-3578

Skup
International conference

Mjesto i datum
International conference, 2004

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
adjuvant chemotherapy

Sažetak
Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT)

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Rajko Ostojić (autor)

Citiraj ovu publikaciju:

McKendrick, J. J; Cassidy, J.; Chakrapee- Sirisuk, S.; Fountzilas, G.; Iveson, T.; Jelic, S.; Karnicka-Mlodkowska, H.; Ostojic, Rajko; Scheithauer, W.; Twelves, C.
Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT) // Journal of Clinical Oncology
International conference, 2004. str. 3578-3578 (predavanje, međunarodna recenzija, sažetak, znanstveni)
McKendrick, J., Cassidy, J., Chakrapee- Sirisuk, S., Fountzilas, G., Iveson, T., Jelic, S., Karnicka-Mlodkowska, H., Ostojic, R., Scheithauer, W. & Twelves, C. (2004) Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT). U: Journal of Clinical Oncology.
@article{article, author = {McKendrick, J. J and Cassidy, J. and Chakrapee- Sirisuk, S. and Fountzilas, G. and Iveson, T. and Jelic, S. and Karnicka-Mlodkowska, H. and Ostojic, Rajko and Scheithauer, W. and Twelves, C.}, year = {2004}, pages = {3578-3578}, keywords = {adjuvant chemotherapy}, title = {Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT)}, keyword = {adjuvant chemotherapy}, publisherplace = {International conference} }
@article{article, author = {McKendrick, J. J and Cassidy, J. and Chakrapee- Sirisuk, S. and Fountzilas, G. and Iveson, T. and Jelic, S. and Karnicka-Mlodkowska, H. and Ostojic, Rajko and Scheithauer, W. and Twelves, C.}, year = {2004}, pages = {3578-3578}, keywords = {adjuvant chemotherapy}, title = {Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients: Medical resource utilization (MRU) data from a large phase III trial (X-ACT)}, keyword = {adjuvant chemotherapy}, publisherplace = {International conference} }

Časopis indeksira:


  • MEDLINE

Podijeli:





Contrast
Increase Font
Decrease Font
Dyslexic Font
CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.